New Developments in Active Surveillance for Prostate Cancer

June 17, 2016

In this peer-to-peer discussion, Dr. Loeb and Dr. Choyke discuss new developments in active surveillance for prostate cancer.

At the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 3–7 in Chicago, Stacy Loeb, MD, of the NYU Langone Medical Center in New York, New York, and Peter L. Choyke, MD, of the National Cancer Institute in Bethesda, Maryland, gave presentations during the education session “Contemporary Active Surveillance for Prostate Cancer: Do We Need Better Imaging and Molecular Testing?”

In this peer-to-peer discussion, Dr. Loeb and Dr. Choyke discuss some of the salient points from their session, including the use of magnetic resonance imaging for patient selection and follow-up and the use of new molecular markers that could signal tumor changes in patients on surveillance.